December 6, 2024 - 02:43

Sari Altschuler, a professor of English, raises concerns about the implications of employing AI scribes for medical note-taking. While the technology promises efficiency and time-saving benefits for healthcare professionals, Altschuler argues that it may inadvertently compromise the quality of patient care.
AI scribes are designed to automate the documentation process, allowing physicians to focus more on patient interaction. However, Altschuler points out that reliance on artificial intelligence for such critical tasks could lead to a decline in the depth and accuracy of medical records. The nuances of patient interactions might be lost in translation, resulting in a less personalized approach to healthcare.
Moreover, the professor emphasizes that the human element in medical documentation is irreplaceable. Physicians often rely on their instincts and understanding of patient history, which AI may not fully capture. As healthcare continues to evolve with technology, the balance between efficiency and quality remains a key concern for practitioners and patients alike.
July 22, 2026 - 08:37
Bradford A&E services downgraded by health watchdogA health watchdog has downgraded the accident and emergency services at Bradford Royal Infirmary following an inspection that uncovered significant concerns. The Care Quality Commission (CQC) found...
July 21, 2026 - 17:42
Rare disease drugmakers try to avoid Trump price cutsPharmaceutical companies that specialize in treatments for rare diseases are scrambling to shield their products from possible price cuts under a potential second Trump administration. During his...
July 21, 2026 - 06:41
The rise of Zyn-like pouches for sleep, health, focus, teethThe success of Zyn nicotine pouches has sparked a wave of copycat products that promise to deliver everything from better sleep to sharper focus, all through a small pouch tucked inside the lip....
July 20, 2026 - 19:14
FDA says it’s still investigating Taylor Farms in cyclosporiasis outbreakThe U.S. Food and Drug Administration has clarified that a false-positive lab result does not alter the `overwhelming epidemiological data` pointing to Taylor Farms as the source of a...